GSEA analysis also identified significant enrichment of a gene signature found upregulated in samples from human colorectal cancer tissue (compared to healthy tissues) uniquely in the colon of Irf1−/− mutants treated with AOM/DSS (Fig. 3D). This evidence concerns the gene IRF1 and colorectal cancer.